Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
International Journal of Molecular Sciences|June 27, 2024
A20 in Kidney Transplantation and AutoimmunityAndreas Kommer, Myriam Meineck, Paul Classen, et al.
Journal of Clinical Medicine|May 14, 2025
Immune Checkpoint Inhibitor-Associated Acute Kidney Injury: A Single-Center Experience of Biopsy-Proven CasesAndreas Kommer, Marco Stortz, Daniel Kraus, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 18, 2024
Proton pump inhibitor use and bone fractures in patients with chronic kidney diseaseAndreas Kommer, Karel Kostev, Eva Maria Schleicher, et al.
Transplant Immunology|September 5, 2024
Long-term survival of kidney-transplant recipient with donor-transmitted malignant melanoma after provoked rejectionAndreas Kommer, Stefan Holtz, Daniel Kraus, et al.
Clinical Kidney Journal|July 4, 2025
Chronic kidney disease is associated with incident depression requiring treatment: a retrospective cohort studyAndreas Kommer, Paul Christoph Claßen, Eva Maria Schleicher, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 13, 2026
Bleeding risk after kidney biopsy with platelet inhibitionDaniel Kraus, Razan Sadek, Andreas Kommer, et al.
Trials|April 2, 2025
Immunoadsorption study Mainz in adults with post-COVID syndrome (IAMPOCO)-a single-blinded sham-controlled crossover trial to evaluate the effect of immunoadsorption on post-COVID syndromeMarco Stortz, Pascal Klimpke, Andreas Kommer, et al.
Clinical and Experimental Rheumatology|September 26, 2025
Anifrolumab in systemic lupus erythematosus: real-world experience from a single academic tertiary care centrePaul Classen, Simone Boedecker-Lips, Vanessa Tomalla, et al.
The Lancet Regional Health. Europe|June 19, 2026
Immunoadsorption Versus Sham Treatment for Post-COVID Syndrome: A Randomised Sham-Controlled Crossover TrialMarco Stortz, Andreas Kommer, Myriam Meineck, et al.
Pageof 1